Amentum (AMTM)
NYSEIndustrialsAerospace & DefenseSnapshot 2026-09-04
$20.06-0.25%
Close 2026-09-04 · 1-day change
NYSEIndustrialsAerospace & DefenseSnapshot 2026-09-04
QuarterlyIQ Insights · AMTM
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 10 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $20 AMTM trades at 8.3× p/e, below its 27× p/e peer median. Our $37 fair value sits well above the price. We hold it with low confidence: our number sits above the analyst range and the peer anchor overstates how cheap it looks. Analysts target $24–$35. Note: our $37 fair value sits above the entire analyst range ($24–$35). Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $26.00 | — | — | Analyst | high |
| dcf fcff | 12M | $42.27 | — | — | Analyst | high |
| graham number | 12M | $32.62 | — | — | TTM | high |
| Peer P/FCF | 12M | $29.68 | 15.4 | 1.93 | TTM | high |
| Peer P/E | 12M |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 25% on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
$24.00 – $35.00 (median $26.00) · 7 analysts · as of 2026-08-20
No fragility gates fired. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks cheaper than most peers in the same business.
Cheaper than its own typical valuation.
Trailing four: 2025-Q3, 2026-Q1, 2026-Q2, 2026-Q3
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
| $64.92 |
| 26.8 |
| 2.42 |
| TTM |
| high |
| Peer P/S | 12M | $101.26 | 1.7 | 58.75 | TTM | high |
| PEG | 12M | $66.16 | 27.3 | 2.42 | TTM | high |
| residual income | 12M | $22.21 | — | — | TTM | high |
| Own P/E history | 12M | $23.49 | 9.7 | 2.42 | TTM | high |
| triangulated | 12M | $70.29 | 26.8 | 2.62 | Triangulated | high |
| Peer P/E | 3Y | $82.67 | 26.8 | 3.08 | Analyst | medium |
| Peer P/S | 3Y | $90.72 | 1.7 | 52.63 | guidance | medium |
| PEG | 3Y | $84.25 | 27.3 | 3.08 | Analyst | medium |
| Own P/E history | 3Y | $29.91 | 9.7 | 3.08 | Analyst | medium |
| Peer P/E | 5Y | $97.13 | 26.8 | 3.62 | Analyst | medium |
| Peer P/S | 5Y | $84.30 | 1.7 | 48.91 | guidance | medium |
| PEG | 5Y | $98.98 | 27.3 | 3.62 | Analyst | medium |
| Own P/E history | 5Y | $35.14 | 9.7 | 3.62 | Analyst | medium |